Philip A. Kern

22.3k citations

194 papers · 17.3k indexed · 6 hit papers · h-index 61

Physiology top 0.05%
Epidemiology top 0.1%
Molecular Biology top 1%
Endocrine and Autonomic Systems top 0.05%
Cardiology and Cardiovascular Medicine top 0.5%

Co-authors: Neda Rasouli Gouri Ranganathan Juling Ong Subramanian Ranganathan Mehrnoosh Saghizadeh Chunling Li R B Simsolo Aiwei Yao‐Borengasser
Topics: Adipose Tissue and Metabolism (84 papers)Adipokines, Inflammation, and Metabolic Diseases (60 papers)Lipid metabolism and disorders (32 papers)
Cited by: Endocrine and Autonomic Systems Physiology Epidemiology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Journal of Biological Chemistry
Partner nations: United States Germany Australia

In The Last Decade

Philip A. Kern

190 papers receiving 16.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

1995 3.1k citations Philip A. Kern et al. profile →
Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance

2001 1.5k citations Philip A. Kern, Gouri Ranganathan et al. profile →
The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.

1995 1.0k citations Philip A. Kern, R B Simsolo et al. Journal of Clinical Investigation profile →
Adiponectin Expression From Human Adipose Tissue

2003 712 citations Philip A. Kern, Gouri Ranganathan et al. profile →
The expression of TNF alpha by human muscle. Relationship to insulin resistance.

1996 586 citations Philip A. Kern et al. Journal of Clinical Investigation profile →
Adipocytokines and the Metabolic Complications of Obesity

2008 582 citations Neda Rasouli, Philip A. Kern profile →

Peers

Countries citing papers authored by Philip A. Kern

Since Specialization

Citations

This map shows the geographic impact of Philip A. Kern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Kern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Kern more than expected).

Fields of papers citing papers by Philip A. Kern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Kern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Kern. The network helps show where Philip A. Kern may publish in the future.

Co-authorship network of co-authors of Philip A. Kern

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Kern. A scholar is included among the top collaborators of Philip A. Kern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Kern. Philip A. Kern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of the association between COVID-19 and new onset diabetes in a regional and national dataset 2025 ·Diabetes Research and Clinical Practice ·Mary E. Lacy,Aaron P. Smith,Lindsey R. Hammerslag,(unknown),James R. Aaron,(unknown),John L. Fowlkes,Simon J. Fisher,Jeffery Talbert,Philip A. Kern	0
2	Students Participating as Ambassadors for Research in Kentucky (SPARK): A health equity undergraduate research training program 2024 ·Journal of Clinical and Translational Science ·(unknown),(unknown),(unknown),(unknown),Carrie B. Oser,Justin B. Moore,(unknown),(unknown),(unknown),Philip A. Kern,Nancy E. Schoenberg	1
3	Optimizing team science in an academic medical center: A qualitative examination of investigator perspectives 2023 ·Journal of Clinical and Translational Science ·Hilary L. Surratt,(unknown),Emily Slade,Philip A. Kern,Victoria King,Thomas H. Kelly,Robert S. DiPaola	2
4	Collaborative team dynamics and scholarly outcomes of multidisciplinary research teams: A mixed-methods approach 2023 ·Journal of Clinical and Translational Science ·Emily Slade,Philip A. Kern,(unknown),(unknown),Joel Thompson,Thomas H. Kelly,Victoria King,Robert S. DiPaola,Hilary L. Surratt	6
5	Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance 2023 ·Antioxidants ·Zachary A. Kipp,Mei Xu,(unknown),(unknown),Philip A. Kern,Terry D. Hinds	31
6	Short-term repeated human biopsy sampling contributes to changes in muscle morphology and higher outcome variability 2023 ·Journal of Applied Physiology ·Douglas E. Long,(unknown),Amy L. Confides,Benjamin F. Miller,Philip A. Kern,Timothy A. Butterfield,Esther E. Dupont‐Versteegden	4
7	Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review 2022 ·BMJ Open Diabetes Research & Care ·Rishi Raj,(unknown),(unknown),(unknown),Ricardo Correa,Philip A. Kern	46
8	Pioglitazone does not synergize with mirabegron to increase beige fat or further improve glucose metabolism 2021 ·JCI Insight ·Brian S. Finlin,Hasiyet Memetimin,Beibei Zhu,Amy L. Confides,Hemendra J. Vekaria,Riham El Khouli,Zachary Johnson,Philip M. Westgate,Jianzhong Chen,Andrew J. Morris,Patrick G. Sullivan,Esther E. Dupont‐Versteegden,Philip A. Kern	12
9	The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans 2020 ·Journal of Clinical Investigation ·Brian S. Finlin,Hasiyet Memetimin,Beibei Zhu,Amy L. Confides,Hemendra J. Vekaria,Riham H. El Khouli,Zachary Johnson,Philip M. Westgate,Jianzhong Chen,Andrew J. Morris,Patrick G. Sullivan,Esther E. Dupont‐Versteegden,Philip A. Kern	167
10	Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults: A randomized, double‐blind, placebo‐controlled, multicenter trial: The MASTERS trial 2019 ·Aging Cell ·R. Grace Walton,Cory M. Dungan,Douglas E. Long,S. Craig Tuggle,Kate Kosmac,Bailey D. Peck,Heather Bush,Alejandro Villasante‐Tezanos,Gerald McGwin,Samuel T. Windham,Fernando Ovalle,Marcas M. Bamman,Philip A. Kern,Charlotte A. Peterson	147
11	IKKβ is a β-catenin kinase that regulates mesenchymal stem cell differentiation 2018 ·JCI Insight ·Yipeng Sui,Zun Liu,Sehyung Park,Sean E. Thatcher,(unknown),Joseph Fernandez,Henrik Molina,Philip A. Kern,Changcheng Zhou	35
12	Sphk2−/− mice are protected from obesity and insulin resistance 2018 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·(unknown),Brian S. Finlin,Philip A. Kern,Sabire Özcan	24
13	Regulation of Small Ubiquitin-Like Modifier-1, Nuclear Receptor Coreceptor, Histone Deacetylase 3, and Peroxisome Proliferator-Activated Receptor-γ in Human Adipose Tissue 2012 ·Metabolic Syndrome and Related Disorders ·Brian S. Finlin,Angela M. Bodles-Brakhop,Aiwei Yao‐Borengasser,Beibei Zhu,Catherine P. Starnes,Robert E. McGehee,Charlotte A. Peterson,Philip A. Kern,Neda Rasouli	2
14	Obesity and Hepatosteatosis in Mice with Enhanced Oxidative DNA Damage Processing in Mitochondria 2011 ·American Journal Of Pathology ·Haihong Zhang,Cheng‐Hui Xie,Horace J. Spencer,Chunlai Zuo,Masahiro Higuchi,Gouri Ranganathan,Philip A. Kern,Ming W. Chou,Qin Huang,Bartosz Szczęsny,Sankar Mitra,Amanda J. Watson,Geoffrey P. Margison,Chun-Yang Fan	16
15	The lipoprotein lipase (LPL) S447X gain of function variant involves increased mRNA translation 2011 ·Atherosclerosis ·Gouri Ranganathan,Reşat Ünal,Irina D. Pokrovskaya,Preeti Tripathi,Jerome I. Rotter,Mark O. Goodarzi,Philip A. Kern	24
16	The prevention and treatment of metabolic syndrome and high-risk obesity 2006 ·Current Opinion in Cardiology ·Behzad Molavi,Neda Rasouli,Philip A. Kern	19
17	Antagonistic Effects of Vitamin D and Parathyroid Hormone on Lipoprotein Lipase in Cultured Adipocytes 1999 ·Journal of the American Society of Nephrology ·Uwe Querfeld,Michael M. Hoffmann,(unknown),Frank Eifinger,(unknown),Dietrich Michalk,Philip A. Kern	99
18	Supportive Pentoxifylline in Falciparum Malaria: No Effect on Tumor Necrosis Factor Alpha Levels or Clinical Outcome: A Prospective, Randomized, Placebo-Controlled Study 1997 ·American Journal of Tropical Medicine and Hygiene ·Christoph Josef Hemmer,(unknown),Collins Batsirai Chiwakata,Rainer Seitz,(unknown),Wilhelm Gaus,Josef Högel,(unknown),(unknown),Philip A. Kern,M. Dietrich	38
19	Effect of gemfibrozil on adipose tissue and muscle lipoprotein lipase 1993 ·Metabolism ·R B Simsolo,John M. Ong,Philip A. Kern	16
20	An enzyme-linked immunoassay for lipoprotein lipase 1987 ·Analytical Biochemistry ·John Goers,M. Elizabeth Pedersen,Philip A. Kern,John M. Ong,Michael C. Schotz	89

About Philip A. Kern

Philip A. Kern is a scholar working on Physiology, Biochemistry and Rehabilitation, having authored 194 papers that have together received 17.3k indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (84 papers), Adipokines, Inflammation, and Metabolic Diseases (60 papers) and Lipid metabolism and disorders (32 papers). The work is most often cited by research in Endocrine and Autonomic Systems (3.7k citations), Physiology (8.1k citations) and Epidemiology (7.0k citations). Philip A. Kern has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Neda Rasouli, Gouri Ranganathan, Juling Ong, Subramanian Ranganathan, Mehrnoosh Saghizadeh, Chunling Li, R B Simsolo, Aiwei Yao‐Borengasser, Margherita Maffei and Tong Lü. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact